Literature DB >> 25736433

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.

N A Koloski1, M Jones, M Young, N J Talley.   

Abstract

BACKGROUND: While the Rome III classification recognises functional constipation (FC) and constipation predominant IBS (IBS-C) as distinct disorders, recent evidence has suggested that these disorders are difficult to separate in clinical practice. AIM: To identify whether clinical and lifestyle factors differentiate Rome III-defined IBS-C from FC based on gastrointestinal symptoms and lifestyle characteristics.
METHOD: 3260 people randomly selected from the Australian population returned a postal survey. FC and IBS-C were defined according to Rome III. The first model used logistic regression to differentiate IBS-C from FC based on lifestyle, quality-of-life and psychological characteristics. The second approach was data-driven employing latent class analysis (LCA) to identify naturally occurring clusters in the data considering all symptoms involved in the Rome III criteria for IBS-C and FC.
RESULTS: We found n = 206 (6.5%; 95% CI 5.7-7.4%) people met strict Rome III FC whereas n = 109 (3.5%; 95% CI 2.8-4.1%) met strict Rome III IBS-C. The case-control approach indicated that FC patients reported an older age at onset of constipation, were less likely to exercise, had higher mental QoL and less health care seeking than IBS-C. LCA yielded one latent class that was predominantly (75%) FC, while the other class was approximately half IBS-C and half FC. The FC-dominated latent class had clearly lower levels of symptoms used to classify IBS (pain-related symptoms) and was more likely to be male (P = 0.046) but was otherwise similar in distribution of lifestyle factors to the mixed class.
CONCLUSION: The latent class analysis approach suggests a differentiation based more on symptom severity rather than the Rome III view.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25736433     DOI: 10.1111/apt.13149

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  21 in total

1.  Prevalence of constipation in the German population - a representative survey (GECCO).

Authors:  Paul Enck; Johannes Leinert; Menno Smid; Thorsten Köhler; Juliane Schwille-Kiuntke
Journal:  United European Gastroenterol J       Date:  2015-08-21       Impact factor: 4.623

2.  Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea.

Authors:  Prashant Singh; Ha-Neul Lee; Vikram Rangan; Sarah Ballou; Joseph Lembo; Jesse Katon; Courtney McMahon; Daniel Friedlander; Johanna Iturrino; Judy Nee; Anthony Lembo
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-20       Impact factor: 11.382

3.  Functional dyspepsia is associated with lower exercise levels: A population-based study.

Authors:  Natasha A Koloski; Michael Jones; Marjorie M Walker; Gerald Holtmann; Nicholas J Talley
Journal:  United European Gastroenterol J       Date:  2020-03-30       Impact factor: 4.623

4.  Chronic Constipation and Constipation-Predominant IBS: Separate and Distinct Disorders or a Spectrum of Disease?

Authors:  Kewin T H Siah; Reuben K Wong; William E Whitehead
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-03

5.  Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT).

Authors:  Phoebe Heenan; Rob H Creemers; Shriya Sharma; Jacqueline Keenan; Simone Bayer; Wayne Young; Janine Cooney; Kelly Armstrong; Karl Fraser; Paula M Skidmore; Nicholas J Talley; Nicole Roy; Richard B Gearry
Journal:  Inflamm Intest Dis       Date:  2020-07-08

6.  Efficacy of non-pharmacological treatment for adult patients with chronic constipation.

Authors:  Maryam Soheilipour; Elham Goudarzinejad; Elham Tabesh
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-08-15

7.  Functional constipation as a neglected condition in laryngectomized patients.

Authors:  Göktuğ Şirin; Seher Şirin
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

8.  Somatic Comorbidity in Chronic Constipation: More Data from the GECCO Study.

Authors:  Paul Enck; Johannes Leinert; Menno Smid; Thorsten Köhler; Juliane Schwille-Kiuntke
Journal:  Gastroenterol Res Pract       Date:  2016-10-16       Impact factor: 2.260

9.  Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past.

Authors:  Ruchit Sood; Alexander C Ford
Journal:  Clin Transl Gastroenterol       Date:  2015-10-08       Impact factor: 4.488

Review 10.  Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.

Authors:  Duo-Chen Jin; Hai-Long Cao; Meng-Que Xu; Si-Nan Wang; Yu-Ming Wang; Fang Yan; Bang-Mao Wang
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.